会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Vascular plug
    • 血管塞
    • US09173659B2
    • 2015-11-03
    • US13804882
    • 2013-03-14
    • COOK MEDICAL TECHNOLOGIES LLC
    • Tue Thuren BodewadtChristina Rauff Hansen
    • A61B17/12
    • A61B17/12109A61B17/12159A61B17/12181
    • A vascular plug includes a plurality of cells which extend from a front face of the plug towards a distal end of the plug. The cells form at least a periphery of the plug and are in the preferred embodiment closed at their distal ends. The cells may form a central chamber to the plug or may extend across the entirety of the front face of the plug. The cells will fill with blood from the patient's vessel, to inflate the plug and create a barrier to fluid flow. Static blood within the plug will clot over time, creating enhanced occlusion. The plug can also be configured as a vascular filter.
    • 血管插塞包括多个细胞,其从插塞的前表面朝向插塞的远端延伸。 细胞至少形成插塞的周边,并且在优选实施例中在其远端处封闭。 电池可以形成到插头的中心室,或者可以延伸穿过插塞的整个前表面。 细胞将填充来自患者血管的血液,使塞子膨胀并产生流体流动的屏障。 塞子内的静电血液会随着时间的推移而凝结,从而产生增强的闭塞。 插头也可以配置为血管过滤器。
    • 9. 发明申请
    • ENDOLUMINAL DRUG DELIVERY DEVICE
    • 内膜药物递送装置
    • US20160045341A1
    • 2016-02-18
    • US14724047
    • 2015-05-28
    • COOK MEDICAL TECHNOLOGIES LLC
    • Steen AggerholmChristina Rauff HansenSean D. Chambers
    • A61F2/844A61F2/958A61F2/90
    • A61M31/00A61F2230/0067A61F2230/0069A61F2250/0065A61F2250/0067A61M2025/105A61M2025/1081
    • A drug delivery device (10) includes expandable element (12) formed of a braided structure having a body portion (16) and first and second end cones (18, 20). The end cones are attached at their necks (22, 24) to a catheter assembly (14). The expandable element (12) can expand to a vessel contacting configuration, in which the body portion (16) contacts the vessel wall. Bioactive agent (28) covers at least the outer surface of the body portion (16) such that bioactive material can be administered to a vessel wall. The end cones (18, 20) have an open structure allowing unrestricted passage of blood through the device (10) in the deployed configuration, such that blood flow can be maintained during the administration of bioactive agent (28) from the device (10). The expandable element (12) can be radially contracted by extending it in the longitudinal direction, both for deployment endoluminally to the treatment site and also for retrieval following the administration of the bioactive material.
    • 药物输送装置(10)包括由具有主体部分(16)和第一和第二端锥体(18,20)的编织结构形成的可膨胀元件(12)。 末端锥体在其颈部(22,24)处连接到导管组件(14)。 可膨胀元件(12)可以膨胀到容器接触构型,其中主体部分(16)接触血管壁。 生物活性剂(28)至少覆盖主体部分(16)的外表面,使得生物活性物质可被施用于血管壁。 末端锥体(18,20)具有允许血液在展开构型中不经限制地通过装置(10)的开放结构,使得在从装置(10)施用生物活性剂(28)期间可以维持血液流动, 。 可膨胀元件(12)可以通过沿纵向方向延伸而被径向收缩,两者用于在内部部署到处理部位并且还用于在施用生物活性材料之后进行回收。